Literature DB >> 3521853

Mechanism(s) of in vitro macrophage activation with Nocardia rubra cell wall skeleton: the effects on macrophage activating factor production by lymphocytes.

T Masuno, S Hayashi, M Ito, T Ikeda, T Ogura, S Kishimoto, Y Yamamura.   

Abstract

BALB/c mouse peritoneal macrophages prepared from WPC which had been treated with N. CWS demonstrated potent cytostatic activity against syngeneic Meth A fibrosarcoma cells. The maximum cytostatic activity developed in the macrophages when WPC were incubated with 25 micrograms/ml N. CWS for 3 days. NAPC from BALB/c mice given an i.p. injection with 100 micrograms N. CWS 7 days previously (N. CWS-NAPC) or supernatants from N. CWS-NAPC also activated peritoneal macrophages in vitro. However, when peritoneal macrophages were incubated with N. CWS in the absence of NAPC, or when T cells were depleted from WPC by treatment with anti-Thy 1.2 antibody and complement, N. CWS failed to enhance the cytostatic activity of the macrophages. Furthermore, thioglycollate-elicited peritoneal macrophages from C3H/HeN mice increased their cytolytic properties by incubation with supernatant fluids from N. CWS-treated spleen cells. These findings suggest that in vitro macrophage activation with N. CWS depends on MAF secreted from T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521853     DOI: 10.1007/bf00199127

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  26 in total

1.  Possible role of macrophage mediated nonspecific cytotoxicity in tumour resistance.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  Nat New Biol       Date:  1972-01-12

2.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

3.  The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.

Authors:  I J Fidler
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  In vitro tumor cell killing by peritoneal macrophages from mitomycin C-treated rats.

Authors:  T Ogura; H Shindo; O Shinzato; M Namba; T Masuno; T Inoue; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

5.  Killing of tumor cells in vitro by macrophages from mice given injections of squalene-treated cell wall skeleton of Nocardia rubra.

Authors:  M Ito; H Iizuka; T Masuno; R Yasunami; T Ogura; Y Yamamura; I Azuma
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

6.  Differential effects of positive and negative proliferative stimuli on murine cytolytic and helper T-cell clones.

Authors:  M D Dick; W R Benjamin; T Masuno; J J Farrar; M K Gately
Journal:  Cell Immunol       Date:  1984-06       Impact factor: 4.868

7.  Randomized controlled study of adjuvant immunotherapy with Nocardia rubra cell wall skeleton for inoperable lung cancer.

Authors:  Y Yamamura; T Ogura; M Sakatani; F Hirao; S Kishimoto; M Fukuoka; M Takada; M Kawahara; K Furuse; O Kuwahara
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

8.  Endotoxin-induced T lymphocyte proliferation.

Authors:  S N Vogel; M L Hilfiker; M J Caulfield
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

9.  Activation of peritoneal macrophages by oil-attached cell-wall skeleton of BCG and Nocardia rubra.

Authors:  T Masuno; M Ito; T Ogura; F Hirao; M Yamawaki; I Azuma; Y Yamamura
Journal:  Gan       Date:  1979-04

10.  Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.

Authors:  W F Doe; P M Henson
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  6 in total

1.  Induction of tumoricidal macrophages from bone marrow cells of normal mice or mice bearing a colony-stimulating-factor-producing tumor.

Authors:  S Hosoe; T Ogura; S Hayashi; K Komuta; T Ikeda; T Shirasaka; I Kawase; T Masuno; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Effect of Nocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages.

Authors:  M Sakatani; T Ogura; T Masuno; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Augmentative effect of Nocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s).

Authors:  T Shirasaka; I Kawase; M Okada; M Kitahara; T Ikeda; K Komuta; S Hosoe; S Yokota; T Masuno; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction.

Authors:  S Yokota; T Shirasaka; H Nishikawa; S Hosoe; T Ikeda; K Komuta; I Kawase; T Masuno; T Ogura; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Effects of periodic administration of Nocardia rubra cell-wall skeleton on immunoglobulin production and B-cell-stimulatory factor activity in vitro in workers at a poison gas factory.

Authors:  S Hozawa; S Ishioka; J Yanagida; M Takaishi; S Matsuzaka; M Ohsaki; M Yamakido
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity.

Authors:  I Kawase; K Komuta; T Shirasaka; H Hara; Y Tanio; M Watanabe; S Saito; T Ikeda; T Masuno; S Kishimoto
Journal:  Jpn J Cancer Res       Date:  1989-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.